TP53 and cancer: ALRN-6942 efficacy was attributed to its cell membrane penetrance capability, together with its high affinity for both MDM2 and MDM4, which frees p53 to selectively inhibit cancer cell growth inhibition, while sparing from general toxicity (Carvajal et al., 2018).